Diabetes Drug That Could Revolutionize Heart Failure Treatment

32 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
This video explores a new meta-analysis from the University of East Anglia showing that SGLT2 inhibitors—such as Jardiance, Farxiga, and Steglatro—significantly reduce hospitalization and cardiovascular death in patients with heart failure with preserved ejection fraction (HFpEF).
Can these diabetes drugs help even non-diabetics with heart failure?
All the science, explained clearly in this episode.

???? Don’t forget to subscribe for more science-backed medical updates.
#HeartFailure,#HFpEF,#SGLT2,#Jardiance,#Farxiga,#Steglatro,#Inpefa,#DiabetesDrugs,#Cardiology,#MedicalResearch,#HeartHealth,#PreventiveCardiology,#UniversityOfEastAnglia,#ScienceNews,#HeartTreatment,#SGLT2Inhibitors,#CardiovascularHealth,#GLP1vsSGLT2,#HospitalizationRisk,#DiabetesMedication
Categoria
Cardiology
Commenta per primo questo video.

Prossimo